NHS

Neuberger Berman High Yield Strategies Fund Inc. [NHS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

NHS Stock Summary

Top 10 Correlated ETFs

NHS


Top 10 Correlated Stocks

NHS


In the News

05:37 11 Dec 2023 NHS

NHS: Not A Bad CEF If You're Prepared For A Distribution Cut

Neuberger Berman High Yield Strategies offers a high yield of 14.46%, higher than other closed-end funds investing in junk bonds. The NHS closed-end fund's net asset value has been declining, raising concerns about the sustainability of its distribution. The NHS fund is doing a reasonably good job at protecting itself from default risk, which seems to be increasing with interest rates.

10:23 11 Dec 2023 NHS

NHS: Don't Ignore The Risk Of More Rate Hikes, Best To DCA Purchases

Neuberger Berman High Yield Strategies offers a remarkable 14.25% distribution yield but has underperformed over the past year due to rising interest rates. The fund primarily invests in junk bonds and aims to provide a high level of current income to investors. The fund employs leverage to boost its yield and total investment returns, but its use of leverage could increase volatility and risk.

09:49 11 Dec 2023 NHS

NHS: 2023 Rights Offering Results

NHS's 2023 rights offering results are in. The offering was oversubscribed, despite the slim discount to the market price. The "sell and rebuy" strategy worked once again.

05:04 11 Dec 2023 NHS

83 Monthly-Paying Dividend Stocks And 80 Funds For May

Imagine stocks or funds that pay out their dividends once-a-month! Unlike waiting for quarterly, semi-annual or (ugh) annual payouts, your angst waiting for money is reduced by 300%, or more! These May U.S. exchange-traded monthly-paid (MoPay) dividends, upsides, and net gains include: 1. Stocks by yield (83); 2. Stocks by price upside (30); 3. Closed-End Investments, Exchange-Traded Funds & Notes (CEICs/ETFs/ETNs) by yield >9.56% (80).

01:49 11 Dec 2023 NHS

NHS: 2023 Rights Offering Quick Notes

Quick notes on Neuberger Berman High Yield Strategies' rights offering this year. Our suggestion is to sell before the ex-rights date and rebuy after the offering.

05:49 11 Dec 2023 NHS

NHS: Time To Reduce Some Exposure To This High Beta HY CEF

NHS is a fixed income closed end fund. The fund focuses on U.S. high yield bonds, which represent 88% of the portfolio.

06:55 11 Dec 2023 NHS

NHS: 13% Yield From A High Duration Bond CEF

NHS is a fixed income closed end fund. Over 88% of the fund holdings are fixed rate high yield bonds.

10:15 11 Dec 2023 NHS

The Month In Closed-End Funds: October 2022

For the first month in three, equity CEFs (+4.49%) on average witnessed plus-side returns, while their fixed income CEF cohorts (-5.07%) suffered a third month of declines in October. Only 17% of all CEFs traded at a premium to their NAV at month end, with 24% of equity CEFs and 11% of fixed income CEFs trading in premium territory.

03:46 11 Dec 2023 NHS

NHS: Rights Offering Quick Notes

NHS's rights offering is now live. The subscription formula has a floor of a -13% discount, at which point one should not subscribe.

04:30 11 Dec 2023 NHS

Neuberger Berman High Yield Strategies Fund Announces Monthly Distribution

NEW YORK, Sept. 30, 2021 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock.

NHS Financial details

Company Rating
Buy
Market Cap
146.17M
Income
29.3M
Revenue
39.15M
Book val./share
-
Cash/share
-
Dividend
1.09
Dividend %
14.44%
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
-3.93
Forward P/E
-
PEG
-0.38
P/S
-4.81
P/B
0.78
P/C
-
P/FCF
-3
Quick Ratio
1.72
Current Ratio
1.72
Debt / Equity
0.28
LT Debt / Equity
0.28
-
-
EPS (TTM)
3.11
EPS next Y
-
EPS next Q
2.09
EPS this Y
-224.84%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
64.2%
Revenue last 5Y
105.21%
Revenue Q/Q
-12.3%
EPS Q/Q
-82.97%
-
-
-
-
SMA20
14.29%
SMA50
-
SMA100
-
Inst Own
17.05%
Inst Trans
0.95%
ROA
-11%
ROE
-19%
ROC
-0.11%
Gross Margin
100%
Oper. Margin
107%
Profit Margin
110%
Payout
-54%
Shs Outstand
19.44M
Shs Float
16.32M
-
-
-
-
Target Price
-
52W Range
6.95-9.4
52W High
-16.75%
52W Low
+24.87%
RSI
56
Rel Volume
1.7
Avg Volume
116.11K
Volume
196.97K
Perf Week
-1.29%
Perf Month
6.27%
Perf Quarter
-1.55%
Perf Half Y
-2.06%
-
-
-
-
Beta
0.975
-
-
Volatility
0.02%, 0.11%
Prev Close
-0.37%
Price
7.4922
Change
0.3%

NHS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-10-31

Metric History 2018-10-312019-10-312020-10-312021-10-31 2022-10-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
-0.041.310.321.68-1.73
Net income per share
-0.161.160.161.53-1.91
Operating cash flow per share
0.831.081.125.95-2.78
Free cash flow per share
0.831.081.125.95-2.78
Cash per share
00.04000
Book value per share
12.5912.7512.1410.349.61
Tangible book value per share
12.5912.7512.1410.349.61
Share holders equity per share
12.5912.7512.1410.349.61
Interest debt per share
4.84.811.841.682.68
Market cap
199.67M231.66M203.04M230.15M143.8M
Enterprise value
289.55M320.82M235.63M259.19M189.69M
P/E ratio
-64.5610.2867.198.59-4.29
Price to sales ratio
-239.29.0833.477.8-4.73
POCF ratio
12.4711.069.592.21-2.95
PFCF ratio
12.4711.069.592.21-2.95
P/B Ratio
0.820.940.891.270.85
PTB ratio
0.820.940.891.270.85
EV to sales
-346.8712.5838.848.78-6.24
Enterprise value over EBITDA
-2.1K14.2477.979.67-5.84
EV to operating cash flow
18.0915.3111.132.49-3.9
EV to free cash flow
18.0915.3111.132.49-3.9
Earnings yield
-0.020.10.010.12-0.23
Free cash flow yield
0.080.090.10.45-0.34
Debt to equity
0.370.360.140.160.27
Debt to assets
0.240.230.090.10.16
Net debt to EBITDA
-652.843.9610.791.08-1.41
Current ratio
1.211.152.860.661.72
Interest coverage
-0.056.631.4362.23-31.93
Income quality
-5.180.9373.891.45
Dividend Yield
0.080.080.10.070.13
Payout ratio
-5.210.817.020.61-0.54
Sales general and administrative to revenue
-0.790.050.230.03-0.02
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
6.7318.246.6118.8720.33
ROIC
00.070.010.13-0.15
Return on tangible assets
-0.010.060.010.09-0.11
Graham Net
-6.61-6.53-6.69-6.19-6.99
Working capital
1.61M1.57M3.79M-2.1M2.58M
Tangible asset value
243.32M247.52M229.32M181.09M168.28M
Net current asset value
-125.44M-123.96M-124.92M-107.4M-120.87M
Invested capital
0.370.360.140.160.27
Average receivables
8.59M10.15M8.43M4.97M5.15M
Average payables
6.94M8.95M6.14M4.14M4.92M
Average inventory
00000
Days sales outstanding
-4.04K158.17349.0151.23-74.08
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
-0.092.311.057.12-4.93
Payables turnover
00000
Inventory turnover
00000
ROE
-0.010.090.010.15-0.2
Capex per share
00000

Quarterly Fundamentals Overview

Last date of statement is 2023-04-30 for Q2

Metric History 2021-04-302021-10-312022-04-302022-10-31 2023-04-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
00000
Operating cash flow per share
00000
Free cash flow per share
00000
Cash per share
00000
Book value per share
00000
Tangible book value per share
00000
Share holders equity per share
00000
Interest debt per share
00000
Market cap
00000
Enterprise value
21.78M29.03M19.32M45.89M45.78M
P/E ratio
00000
Price to sales ratio
00000
POCF ratio
00000
PFCF ratio
00000
P/B Ratio
00000
PTB ratio
00000
EV to sales
00000
Enterprise value over EBITDA
00000
EV to operating cash flow
00000
EV to free cash flow
00000
Earnings yield
00000
Free cash flow yield
00000
Debt to equity
0.130.160.130.270.28
Debt to assets
0.080.10.080.160.15
Net debt to EBITDA
00000
Current ratio
1.570.661.651.720.88
Interest coverage
00000
Income quality
00000
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
00000
ROIC
00000
Return on tangible assets
00000
Graham Net
00000
Working capital
2.54M-2.1M2M2.58M-1.24M
Tangible asset value
185.91M181.09M153.76M168.28M166.18M
Net current asset value
-97.69M-107.4M-94.39M-120.87M-123.93M
Invested capital
0.130.160.130.270.28
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
00000
Payables turnover
00000
Inventory turnover
00000
ROE
00000
Capex per share
00000

NHS Frequently Asked Questions

What is Neuberger Berman High Yield Strategies Fund Inc. stock symbol ?

Neuberger Berman High Yield Strategies Fund Inc. is a US stock , located in New york of Ny and trading under the symbol NHS

What is Neuberger Berman High Yield Strategies Fund Inc. stock quote today ?

Neuberger Berman High Yield Strategies Fund Inc. stock price is $7.4922 today.

Is Neuberger Berman High Yield Strategies Fund Inc. stock public?

Yes, Neuberger Berman High Yield Strategies Fund Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap